Updated pre-eclampsia management guideline published
The document brings together revised recommendations on first-trimester screening, aspirin prophylaxis and the optimal timing of delivery.
The MFM Georgia hypertensive disorders working group has completed its revision of the national pre-eclampsia management guideline. The updated version draws on systematic reviews published between 2023 and 2025 together with the results of a local practice audit.
What has changed
The main change concerns combined first-trimester screening. The document recommends assessing maternal history, mean arterial pressure, uterine artery pulsatility index and PlGF together at 11–13+6 weeks — wherever the test is available.
For the high-risk group the aspirin dose is now set at 150 mg taken in the evening, started before week 12 and continued to week 36. The previous 75–100 mg range is retained only where a higher dose is contraindicated.
Timing of delivery
In pre-eclampsia without severe features, delivery is recommended at 37 weeks. Where severe features are present, delivery from 34 weeks is advised once the mother is stabilised and corticosteroid prophylaxis has been given.
A guideline does not replace clinical judgement in an individual case — it defines the expected standard, and any departure from it should be documented and justified.
Implementation
The document is freely available in Georgian and English. A series of regional workshops begins in September across nine centres, covering practical implementation questions and audit indicators.
